Loading chat...
ID H0339
Bill
Status
3/7/2018
Primary Sponsor
Health and Welfare Committee
Click for details
AI Summary
-
Allows licensed prescribers to authorize pharmacists to substitute a drug with another drug in the same therapeutic class if the prescriber indicates "therapeutic substitution allowed" or similar designation
-
Requires drug product substitution to be intended for formulary compliance with the patient's health insurance plan or to lower patient costs while maintaining safety
-
Requires patient opt-in and clear notification of differences between drug products, with the patient's right to refuse the substitution
-
Requires modification of prescriber's directions to allow equivalent drug amounts and notification to the original prescriber within five (5) business days of dispensing
-
Excludes biological products and narrow therapeutic index drugs from the substitution provisions
Legislative Description
Adds to existing law to establish provisions regarding certain drug product substitutions.
PHARMACY
Last Action
Reported Signed by Governor on March 7, 2018 Session Law Chapter 35 Effective: 07/01/2018
3/7/2018